BCWORLD PHARM. Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 2.37%

BCWORLD PHARM. Co. Ltd (200780) has an Asset Resilience Ratio of 2.37% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 200780 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩4.13 Billion

≈ $2.80 Million USD Cash + Short-term Investments

Total Assets

₩173.79 Billion

≈ $117.78 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how BCWORLD PHARM. Co. Ltd's Asset Resilience Ratio has changed over time. See how leveraged is BCWORLD PHARM. Co. Ltd's balance sheet to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down BCWORLD PHARM. Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is BCWORLD PHARM. Co. Ltd worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩4.13 Billion	2.37%
Total Liquid Assets	₩4.13 Billion	2.37%

Asset Resilience Insights

Limited Liquidity: BCWORLD PHARM. Co. Ltd maintains only 2.37% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

BCWORLD PHARM. Co. Ltd Industry Peers by Asset Resilience Ratio

Compare BCWORLD PHARM. Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
AstraZeneca PLC NASDAQ:AZN	Drug Manufacturers - General	0.10%
AstraZeneca PLC NYSE:AZN	Drug Manufacturers - General	0.10%
Novartis AG SW:NOVN	Drug Manufacturers - General	0.08%
Pfizer Inc NYSE:PFE	Drug Manufacturers - General	5.48%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	5.48%
GuangYuYuan Chinese Herbal Medicine Co Ltd SHG:600771	Drug Manufacturers - General	1.97%
Hubei Guangji Pharmaceutical Co Ltd SHE:000952	Drug Manufacturers - General	5.37%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%

Annual Asset Resilience Ratio for BCWORLD PHARM. Co. Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for BCWORLD PHARM. Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	4.49%	₩7.91 Billion ≈ $5.36 Million	₩176.31 Billion ≈ $119.48 Million	-1.58pp
2023-12-31	6.06%	₩11.16 Billion ≈ $7.57 Million	₩184.11 Billion ≈ $124.77 Million	+1.66pp
2022-12-31	4.40%	₩8.06 Billion ≈ $5.46 Million	₩183.05 Billion ≈ $124.05 Million	+1.89pp
2021-12-31	2.51%	₩4.50 Billion ≈ $3.05 Million	₩179.36 Billion ≈ $121.55 Million	-4.00pp
2020-12-31	6.51%	₩12.56 Billion ≈ $8.51 Million	₩192.96 Billion ≈ $130.77 Million	+4.51pp
2019-12-31	2.00%	₩3.46 Billion ≈ $2.34 Million	₩172.78 Billion ≈ $117.09 Million	-0.95pp
2018-12-31	2.95%	₩4.77 Billion ≈ $3.23 Million	₩161.74 Billion ≈ $109.61 Million	-1.46pp
2017-12-31	4.41%	₩5.22 Billion ≈ $3.54 Million	₩118.34 Billion ≈ $80.20 Million	+1.70pp
2016-12-31	2.71%	₩2.61 Billion ≈ $1.77 Million	₩96.42 Billion ≈ $65.34 Million	--

pp = percentage points

About BCWORLD PHARM. Co. Ltd

KQ:200780 Korea Drug Manufacturers - General

Market Cap

$24.25 Million

₩35.78 Billion KRW

Market Cap Rank

#24514 Global

#1738 in Korea

Share Price

₩3500.00

Change (1 day)

+0.43%

52-Week Range

₩3480.00 - ₩5870.00

All Time High

₩30700.49